ESCRS 2023: Networking highlights from this year's congress in Vienna, Austria

News
Video

Attendees share their favorite moments and memories from the 2023 ESCRS meeting

There’s no doubt about it: the annual European Society of Cataract and Refractive Surgeons (ESCRS) meeting has become a must-attend event. We spoke to a number of attendees and presenters about the incredible opportunities at this year’s meeting, including future-focused symposia, networking in the exhibit hall and a once-in-a-lifetime formal gala. Watch the video – or read the transcript below – to hear meeting memories from Keith Barton, MD, FRCP, FRCS, FRCOphth; AnnMarie Hipsley, DPT, PhD; Rohit Shetty, DNB, FRCS, PhD; and Olivier Benoit.

Our newsletter subscribers receive exclusive, first-look access to bonus conference coverage. To subscribe to our eNewsletter, please click here.


Editor's note: The below transcript has been lightly edited for clarity.

Keith Barton: See, I'm a glaucoma specialist. So historically ESCRS wouldn't have been my main meeting. However, ESCRS, in the last number of years, has grown so much, that it's clearly the second-most influential and biggest group in the world after AAO. So it's really expanding all the time and increasing in importance. And you see that for the vast number of new enterprises that ESCRS is undertaking. It becomes, really, an essential place to come to network, like AAO. It's now a meeting that you don't miss.

AnnMarie Hipsley: I thought Oliver Findl just outdid himself with the President's Ball. That was, by far, the most wonderful social event. It allowed me to see all my colleagues that in just one place, you don't have to race around, trying to find them. It was just so nice to be able to see all the people that you haven't seen in that one place in that fabulous event. And it was just a wonderful, wonderful experience. So, I'm sorry, I'm biased. The sessions were great! But the ball was incredible. And I think people will be talking about that ball for a very long time.

Rohit Shetty: What I'm really excited [about] is the way ESCRS is synchronously going with the changes in the world today. Sustainability, carbon footprinting, and the way you manage your waste, the way people are talking about, you know, being very considerate towards the environment. I think as a society, I see this happening extensively, and [at] this ESCRS. And I'm sure it's going to happen more. And what I'm excited also about is new programmes, like we have the Arena, we have this innovation, iNovation Days. I think these things are going to bring industry and the researchers closer.

Olivier Benoit: For us, that's the event of the year. This is where we come to meet everyone: we come to meet our old friends, we come to meet doctors, the industry, we see the innovation. We–every year, we see that there's a step forward in medical care, the improvements. That's, that's always a very exciting moment for us.


Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
Related Content
© 2025 MJH Life Sciences

All rights reserved.